| 摘要 |
FIELD: medicine.SUBSTANCE: invention refers to medicine, namely oncology and concerns treating lung cancer, particularly its non-small cell form. For this purpose, a radical surgery is followed by administering cytostatics according to the standard technique on the 1, 3and 5day of an adjuvant therapy. On the 2, 4and 6day, there are performed transfusions of autogenous blood incubated with ingaron 500000 IU per mof a patient's body surface, but no more than 1000000 IU per one injection. The incubation is carried out for 3 hours at a temperature of 37°C. Three courses are performed.EFFECT: method provides higher clinical effectiveness in relieving side effects ensured by enhancing the anticancer and antiproliferative action of ingaron.2 ex |
